Ronald Barliant

Insider Reports History

Entity
Individual
Signature
/s/ Henry Madrid, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald Barliant:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HUMANIGEN, INC Director Stock Option (Right to Buy) 55.6K $252K $4.53 Jul 27, 2022 Direct

Insider Reports Filed by Ronald Barliant

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HGEN HUMANIGEN, INC Jul 27, 2022 1 $0 4 Jul 29, 2022 Director
HGEN HUMANIGEN, INC Dec 31, 2021 1 $11.8K 4 Jan 4, 2022 Director